PillLosartan Potassium And Hydrochlorothiazide
Hydrochlorothiazide + Losartan Potassium
5 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it5 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Lupin Pharmaceuticals,Inc. | unknown | 6 | SUPPLYING |
| A-S Medication Solutions | unknown | 4 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | unknown | 4 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 3 | SUPPLYING |
| Direct_Rx | unknown | 2 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Mar 31, 2022RECALLRecall (Class II): Losartan Potassium and Hydrochlorothiazide Tablets USP, 100 mg/25 mg a) 30-count bottles (NDC# 68180-217-06) b) 90-co…
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed nationwide
- Mar 31, 2022RECALLRecall (Class II): Losartan Potassium and Hydrochlorothiazide Tablets USP, 100 mg/12.5 mg a) 30-count bottles (NDC# 68180-216-06) b) 90-…
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed nationwide
- Mar 31, 2022RECALLRecall (Class II): Losartan Potassium and Hydrochlorothiazide Tablets USP, 50 mg/12.5 mg a) 30-count bottles (NDC# 68180-215-06) b) 90-c…
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed nationwide